Application of the ELFI-TECH monitor for measurement of nociception

Application of the ELFI-TECH monitor for measurement of nociception - ELFITOR 2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42818

Enrollment

Registered

2015-07-14

Start date

2015-11-12

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

monitoring hemodynamics pain measurements

Interventions

Remifentanil infusion (blood target concentration 2 ng/ml) Pain testing

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects of either sex, aged 18-34 years with a body mass index

Exclusion criteria

Exclusion criteria: Severe medical disease including hypertension, liver/renal disease, neurological disorders, diaphragmatic hernia/pyrosis; (history of) psychiatric or neurological disease; pregnancy/lactation; allergy to study medication; (history of) illicit drug abuse/alcoholism.

Design outcomes

Primary

Measure	Time frame
Elfitor	—

Secondary

Measure	Time frame
Cardiac output Blood pressure Pulse oximetry ECG monitoring NoL	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)